Lanzamiento Enero 2027

Estudio2019

Relationship between 25-Hydroxyvitamin D, bone density, and Parkinson's disease symptoms

Zhang HJ, Zhang JR, Mao CJ, Li K, Wang F, Chen J, Liu CF

Acta neurologica Scandinavica · 29 citas

Cómo se estudió

Diseño
Estudio transversal (clasificado por nuestro filtro de IA)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
Government of Jiangsu Province
Gobierno
National Key Research and Development Program of China
Universidad u hospital
Suzhou Clinical Research Center of Neurological Disease
Gobierno
Social development projects in Jiangsu Province
Gobierno
National Key R&D Program of China
Gobierno
Jiangsu Provincial Medical Key Discipline Project
Subvenciones
Government of Jiangsu Province (BE2018658); National Key Research and Development Program of China (2017YFC 0909100); Government of Jiangsu Province (BE2017653); Government of Jiangsu Province (ZDXKB2016022)

Según 6 financiadores declarados.

Publicación

Publicado
2019-08-06 · Acta Neurol Scand · vol. 140 · número 4 · págs. 274–280
Editorial
Wiley
Citado
39 citas · más que el 89% de estudios similares · 2.4× el promedio de su campo
Referencias
48 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Vitamin D Research Studies · Bone health and osteoporosis research · Parathyroid Disorders and Treatments
Palabras clave
Medicine, Internal medicine, Vitamin D and neurology, Femoral neck, Bone mineral, Depression (economics), Pittsburgh Sleep Quality Index, Endocrinology, vitamin D deficiency, Anxiety, Parkinson's disease, Bone density, Gastroenterology, Osteoporosis, Disease, Insomnia, Sleep quality, Psychiatry
MeSH
femur neck, lumbar vertebrae, humans, parkinson disease, vitamin d deficiency, vitamin d, absorptiometry, photon, accidental falls, bone density, aged, middle aged, female, male

7 autores

  • Huijun Zhang🇨🇳Soochow University; Second Affiliated Hospital of Soochow University
  • Jin‐Ru Zhang🇨🇳Soochow University; Second Affiliated Hospital of Soochow University
  • Chengjie Mao🇨🇳Soochow University; Second Affiliated Hospital of Soochow University
  • Kai Li🇨🇳Soochow University; Second Affiliated Hospital of Soochow University
  • Fen Wang🇨🇳Soochow University
  • Jing Chen🇨🇳 · autor de correspondenciaSoochow University; Second Affiliated Hospital of Soochow University
  • Chun‐Feng Liu🇨🇳 · autor de correspondenciaSoochow University; Second Affiliated Hospital of Soochow University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objectives

Vitamin D deficiency is widespread in patients with Parkinson's disease (PD). Our aim was to determine whether serum vitamin D levels correlated with bone mineral density (BMD) and non-motor symptoms in patients with PD.

Materials & methods

A consecutive series of 182 patients with PD and 185 healthy controls were included. Serum 25-hydroxyvitamin D (25[OH]D) levels were measured by immunoassay, while BMD of the lumbar spine and femoral neck was measured by dual-energy X-ray absorptiometry. Associations between serum vitamin D levels and clinical data were evaluated using partial correlation analysis.

Results

Patients with PD had significantly lower serum 25(OH)D levels relative to healthy controls (49.75 ± 14.11 vs 43.40 ± 16.51, P < 0.001). Furthermore, PD patients with lower vitamin D levels had a significantly higher frequency of falls (P = 0.033) and insomnia (P = 0.015). They also had significantly higher scores for the Pittsburgh Sleep Quality Index (PSQI; P = 0.014), depression (P = 0.020), and anxiety (P = 0.009). Finally, patients with PD also had a significantly lower mean BMD of the lumbar spine (P = 0.011) and femoral neck (P < 0.001). After adjusting for age, sex, and body mass index, vitamin D levels significantly correlated with falls, insomnia, and scores for the PSQI, depression, and anxiety.

Conclusions

In patients with PD, vitamin D levels significantly correlated with falls and some non-motor symptoms. However, no associations were found between BMD and the serum 25(OH)D levels in patients with PD. Thus, vitamin D supplementation is a potential therapeutic for non-motor PD symptoms.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.